Fernando de la Portilla
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Fernando de la Portilla has a total of 387 co-authors. Here are the top co-authors by number of shared publications:
- Rosa María Jiménez Rodríguez
Attending Colorectal Surgeon, Colorectal Surgery Department at Hospital Universitario Virgen del Rocío, Sevilla, Spain
8 shared publications María Luisa Reyes Díaz
Department of General and Digestive Surgery, University Hospital Virgen del Rocío, Seville, Spain
7 shared publicationsFrancisco Javier Padillo
Unit of coloproctology, Department of Surgery Hospital Universitario Virgen del Rocio Sevilla Spain
5 shared publications- Irene Ramallo Solís
Colorectal Unit, Department of General Surgery Hospital Universitario Virgen del Rocio Sevilla Spain
5 shared publications - Javier Padillo-Ruiz
General Surgery Department, Hospital Universitario Virgen del Rocio, Sevilla, Spain
5 shared publications José M. Díaz Pavón
Spanish National Research Council
5 shared publications
Latest Publications
- Open Access
Multi-Component 3D Bioprinted Platform with Sacrificial Matrix and Collagen-Based Bioinks for Skeletal Muscle Tissue Engineering
The development of biomimetic and mechanically functional constructs remains a major challenge in skeletal muscle tissue engineering. In this study, we present a multi-component 3D bioprinted platform integrating a polycaprolactone (PCL) support for mechanical stimulation, a sacrificial gelatin (GE) matrix for controlled bioink deposition, and collagen-based bioinks laden with Rattus norvegicus L6 skeletal muscle cells. The influence of PCL architecture, GE concentration (0.75, 1.5 and 3 wt%), and bioink composition—collagen (C), collagen–Matrigel (CM), and extracellular matrix-based (ECM)—was systematically evaluated. Rheological characterization demonstrated that all bioinks exhibited shear-thinning behavior and suitable viscoelastic properties for extrusion-based bioprinting, with sufficient mechanical stability to withstand dynamic bioreactor conditions. Microstructural analysis revealed highly interconnected porous networks, particularly in ECM-based scaffolds. While no statistically significant differences were observed, the ECM-based bioinks showed the highest cell viability and improved structural organization. Overall, this work demonstrates a versatile bioprinting strategy that combines mechanical support and biomimetic environments, highlighting the potential of ECM-based bioinks for the fabrication of functional skeletal muscle constructs.
Open AccessMulti-Component 3D Bioprinted Platform with Sacrificial Matrix and Collagen-Based Bioinks for Skeletal Muscle Tissue Engineering
The development of biomimetic and mechanically functional constructs remains a major challenge in skeletal muscle tissue engineering. In this study, we present a multi-component 3D bioprinted platform integrating a polycaprolactone (PCL) support for mechanical stimulation, a sacrificial gelatin (GE) matrix for controlled bioink deposition, and collagen-based bioinks laden with Rattus norvegicus L6 skeletal muscle cells. The influence of PCL architecture, GE concentration (0.75, 1.5 and 3 wt%), and bioink composition—collagen (C), collagen–Matrigel (CM), and extracellular matrix-based (ECM)—was systematically evaluated. Rheological characterization demonstrated that all bioinks exhibited shear-thinning behavior and suitable viscoelastic properties for extrusion-based bioprinting, with sufficient mechanical stability to withstand dynamic bioreactor conditions. Microstructural analysis revealed highly interconnected porous networks, particularly in ECM-based scaffolds. While no statistically significant differences were observed, the ECM-based bioinks showed the highest cell viability and improved structural organization. Overall, this work demonstrates a versatile bioprinting strategy that combines mechanical support and biomimetic environments, highlighting the potential of ECM-based bioinks for the fabrication of functional skeletal muscle constructs.
- 12 February 2026
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 69 (5) , 792-800
Treatment of Anal Fistula in Crohn’s Disease With Platelet-Rich Plasma: Long-term Results
BACKGROUND: Approximately 90% of patients with anal fistulas secondary to Crohn’s disease require surgical intervention. An ideal technique that achieves high cure rates with minimal complications and low recurrence has yet to be established. In other medical disciplines, platelet-rich plasma has demonstrated regenerative and healing properties, offering new therapeutic possibilities. OBJECTIVE: This study aimed to evaluate the 5-year healing rate in patients with anal fistulas due to Crohn’s disease following treatment with platelet-rich plasma. DESIGN: This prospective observational study was conducted between 2011 and 2022. Patients with Crohn’s disease and perianal fistulas who met the inclusion criteria were treated with platelet-rich plasma. Follow-up assessments were carried out at 1, 3, 6, 12, 36, and 60 months. SETTINGS: A single tertiary referral center. PATIENTS: Data from eligible patients with Crohn´s disease-associated anal fistulas were analyzed. MAIN OUTCOME MEASURES: Primary outcomes included fistula healing and recurrence rates, continence status, and complications. RESULTS: A total of 42 patients (45.2% male, 54.8% female; mean age 38.6 ± 11.9 years) were included. 97.6% were receiving active treatment for Crohn´s disease. All procedures were performed on an outpatient basis. Transsphincteric fistulas accounted for 80.9% of cases, 95.2% of which were recurrent. The median time to recurrence was 55±8 months (95% CI: 38–72). Follow-up was completed by 40, 24, and 19 patients at 1, 3, and 5 years, respectively. Mild complications occurred in 23.8% of patients, and continence was preserved, except for one patient. Kaplan–Meier analysis revealed recurrence free-healing of 83.5% at 1 year, 52.5% at 3 years, and 43.8% at 5 years. LIMITATIONS: Include its single-center design and the predominance of transsphincteric fistulas among the cases. CONCLUSIONS: Platelet-rich plasma treatment for anal fistulas in Crohn´s disease patients is safe, feasible in an outpatient setting, and associated with high healing rates and low recurrence. (See Video Abstract )
- 12 February 2026
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 69 (5) , 792-800
Treatment of Anal Fistula in Crohn’s Disease With Platelet-Rich Plasma: Long-term Results
BACKGROUND: Approximately 90% of patients with anal fistulas secondary to Crohn’s disease require surgical intervention. An ideal technique that achieves high cure rates with minimal complications and low recurrence has yet to be established. In other medical disciplines, platelet-rich plasma has demonstrated regenerative and healing properties, offering new therapeutic possibilities. OBJECTIVE: This study aimed to evaluate the 5-year healing rate in patients with anal fistulas due to Crohn’s disease following treatment with platelet-rich plasma. DESIGN: This prospective observational study was conducted between 2011 and 2022. Patients with Crohn’s disease and perianal fistulas who met the inclusion criteria were treated with platelet-rich plasma. Follow-up assessments were carried out at 1, 3, 6, 12, 36, and 60 months. SETTINGS: A single tertiary referral center. PATIENTS: Data from eligible patients with Crohn´s disease-associated anal fistulas were analyzed. MAIN OUTCOME MEASURES: Primary outcomes included fistula healing and recurrence rates, continence status, and complications. RESULTS: A total of 42 patients (45.2% male, 54.8% female; mean age 38.6 ± 11.9 years) were included. 97.6% were receiving active treatment for Crohn´s disease. All procedures were performed on an outpatient basis. Transsphincteric fistulas accounted for 80.9% of cases, 95.2% of which were recurrent. The median time to recurrence was 55±8 months (95% CI: 38–72). Follow-up was completed by 40, 24, and 19 patients at 1, 3, and 5 years, respectively. Mild complications occurred in 23.8% of patients, and continence was preserved, except for one patient. Kaplan–Meier analysis revealed recurrence free-healing of 83.5% at 1 year, 52.5% at 3 years, and 43.8% at 5 years. LIMITATIONS: Include its single-center design and the predominance of transsphincteric fistulas among the cases. CONCLUSIONS: Platelet-rich plasma treatment for anal fistulas in Crohn´s disease patients is safe, feasible in an outpatient setting, and associated with high healing rates and low recurrence. (See Video Abstract )
- 1 January 2026
- Published by Editorial Universidad de Sevilla in Innova medica: revista de innovación docente de la Facultad de Medicina de Sevilla
- Vol. 1 (4) , 19-26
Gestión del cambio y transformación digital en la docencia médica en la Universidad de Sevilla: una propuesta basada en Lewin y ADKAR.
La Facultad de Medicina de la Universidad de Sevilla afronta la transformación digital desde una base tecnológica consolidada, aunque con importantes desigualdades en su uso y aplicación docente. Este trabajo tiene como objetivo diseñar y justificar un modelo integral de transformación digital basado en los modelos de gestión del cambio de Lewin y ADKAR, orientado a mejorar la calidad educativa y la coherencia institucional. Se plantea una propuesta de innovación educativa de carácter teórico, sin evaluación empírica, que combina un enfoque organizativo estructural con una perspectiva centrada en el cambio individual del profesorado. La propuesta integra intervenciones pedagógicas, tecnológicas y organizativas, incluyendo formación en competencia digital, uso de herramientas de evaluación digital, inteligencia artificial aplicada al aprendizaje y simulación clínica. Los resultados esperados apuntan a una mayor aceptación del cambio, mejora de las competencias digitales del profesorado, optimización de procesos docentes y consolidación de una cultura digital institucional. Asimismo, se prevé una mayor eficiencia operativa y una enseñanza más adaptada al entorno digital. En conclusión, el modelo propuesto ofrece un enfoque estratégico, sistémico y transferible que favorece una transformación sostenible de la educación médica, alineada con estándares europeos y demandas del siglo XXI.
- 1 January 2026
- Published by Editorial Universidad de Sevilla in Innova medica: revista de innovación docente de la Facultad de Medicina de Sevilla
- Vol. 1 (4) , 19-26
Gestión del cambio y transformación digital en la docencia médica en la Universidad de Sevilla: una propuesta basada en Lewin y ADKAR.
La Facultad de Medicina de la Universidad de Sevilla afronta la transformación digital desde una base tecnológica consolidada, aunque con importantes desigualdades en su uso y aplicación docente. Este trabajo tiene como objetivo diseñar y justificar un modelo integral de transformación digital basado en los modelos de gestión del cambio de Lewin y ADKAR, orientado a mejorar la calidad educativa y la coherencia institucional. Se plantea una propuesta de innovación educativa de carácter teórico, sin evaluación empírica, que combina un enfoque organizativo estructural con una perspectiva centrada en el cambio individual del profesorado. La propuesta integra intervenciones pedagógicas, tecnológicas y organizativas, incluyendo formación en competencia digital, uso de herramientas de evaluación digital, inteligencia artificial aplicada al aprendizaje y simulación clínica. Los resultados esperados apuntan a una mayor aceptación del cambio, mejora de las competencias digitales del profesorado, optimización de procesos docentes y consolidación de una cultura digital institucional. Asimismo, se prevé una mayor eficiencia operativa y una enseñanza más adaptada al entorno digital. En conclusión, el modelo propuesto ofrece un enfoque estratégico, sistémico y transferible que favorece una transformación sostenible de la educación médica, alineada con estándares europeos y demandas del siglo XXI.
- 26 September 2025
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 68 (12) , e1958
Response to: Toward Standardization of Platelet-Rich Plasma Therapy for Anal Fistula
- 26 September 2025
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 68 (12) , e1958
Response to: Toward Standardization of Platelet-Rich Plasma Therapy for Anal Fistula
- 7 May 2025
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 68 (8) , 992-1000
Long-term Outcomes of Primary Fistula Closure With Platelet-Rich Plasma: A Prospective Study
BACKGROUND: Treating complex perianal fistula remains a challenge, and finding surgical techniques that guarantee high cure rates without compromising continence is necessary. Platelet-rich plasma has been studied in different disciplines, with treatment being successful due to its properties as a tissue regenerator. OBJECTIVE: To assess the 5-year cure rate and complications among patients with complex perianal fistula treated with plasma therapy. DESIGN: A prospective, observational study conducted from 2011 to 2022. Patients with complex perianal fistula who met the inclusion criteria were treated with plasma rich in growth factors. Follow-up and assessment were performed for 5 years after treatment, with visits at 1, 3, 6, 12, 36, and 60 months. SETTING: This study was conducted at a single tertiary referral center. PATIENTS: Data from 166 patients were assessed. MAIN OUTCOME MEASURES: The primary outcome measure was the rate of fistula healing and the secondary outcome measures assessed recurrence, continence status, and complications. RESULTS: A total of 166 patients with cryptoglandular complex perianal fistula (68.7% men, mean age 51.4 ± 13.2 years) were included. The majority of the fistulas (88.5%) were transsphincteric; 87.8% were relapsed fistulas, with a mean of 3.3 ± 3.1 previous procedures. The median time to recurrence-free healing was 26 ± 5 months (95% CI, 16–36). The 1-year follow-up was completed by 154 patients, 3-year follow-up by 140 patients, and 5-year follow-up by 132 patients. The estimated healing rate decreased over time, reaching 70.9% at 1 year, 42.8% at 3 years, and 24.3% at 5 years. Complications were absent in 92.7% of the cases. No changes in continence were observed in any patients. LIMITATIONS: Most patients presented with transsphincteric anal fistulas. CONCLUSIONS: Treatment of complex cryptoglandular anal fistula with platelet-rich plasma is safe and feasible in the long term. See Video Abstract. RESULTADOS A LARGO PLAZO DEL CIERRE PRIMARIO DE FÍSTULAS CON PLASMA RICO EN PLAQUETAS: UN ESTUDIO PROSPECTIVO: ANTECEDENTES: El tratamiento de las fístulas perianales complejas sigue siendo un reto y es necesario encontrar técnicas quirúrgicas que garanticen altas tasas de curación sin comprometer la continencia. El plasma rico en plaquetas se ha estudiado en diferentes disciplinas, y el tratamiento ha tenido éxito gracias a sus propiedades como regenerador de tejidos. OBJETIVO: Evaluar la tasa de curación a 5 años y las complicaciones en pacientes con fístulas perianales complejas tratadas con terapia con plasma. DISEÑO: Estudio prospectivo y observacional realizado entre el 2011 y el 2022. Los pacientes con fístula perianal compleja que cumplían los criterios de inclusión fueron tratados con plasma rico en factores de crecimiento. Se realizó un seguimiento y una evaluación durante 5 años después del tratamiento, con visitas a los 1, 3, 6, 12, 36 y 60 meses. ENTORNO: Este estudio se llevó a cabo en un único centro terciario de referencia. PACIENTES: Se evaluaron los datos de 166 pacientes. PRINCIPALES MEDIDAS DE RESULTADO: La medida de resultado principal fue la tasa de curación de la fístula y las medidas de resultado secundarias evaluaron la recurrencia, el estado de continencia y las complicaciones. RESULTADOS: Se incluyó un total de 166 pacientes con fístula perianal compleja criptoglandular (68,7 % hombres, edad media 51,4 ± 13,2 años). La mayoría de las fístulas (88,5 %) eran transesfinterianas; el 87,8 % eran fístulas recidivantes, con una media de 3,3 ± 3,1 procedimientos previos. El tiempo mediano hasta la curación sin recidivas fue de 26 ± 5 meses (IC del 95 %: [16-36]). El seguimiento de 1 año se completó en 154 pacientes, el de 3 años en 140 pacientes y el de 5 años en 132 pacientes. La tasa de curación estimada disminuyó con el tiempo, alcanzando el 70,9 % al año, el 42,8 % a los 3 años y el 24,3 % a los 5 años. No se observaron complicaciones en el 92,7 % de los casos. No se observaron cambios en la continencia en ningún paciente. LIMITACIONES: La mayoría de los pacientes presentaban fístulas anales transesfintericas. CONCLUSIONES: El tratamiento de la fístula anal criptoglandular compleja con plasma rico en plaquetas es seguro y viable a largo plazo. (Traducción—Yesenia Rojas-Khalil)
- 7 May 2025
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 68 (8) , 992-1000
Long-term Outcomes of Primary Fistula Closure With Platelet-Rich Plasma: A Prospective Study
BACKGROUND: Treating complex perianal fistula remains a challenge, and finding surgical techniques that guarantee high cure rates without compromising continence is necessary. Platelet-rich plasma has been studied in different disciplines, with treatment being successful due to its properties as a tissue regenerator. OBJECTIVE: To assess the 5-year cure rate and complications among patients with complex perianal fistula treated with plasma therapy. DESIGN: A prospective, observational study conducted from 2011 to 2022. Patients with complex perianal fistula who met the inclusion criteria were treated with plasma rich in growth factors. Follow-up and assessment were performed for 5 years after treatment, with visits at 1, 3, 6, 12, 36, and 60 months. SETTING: This study was conducted at a single tertiary referral center. PATIENTS: Data from 166 patients were assessed. MAIN OUTCOME MEASURES: The primary outcome measure was the rate of fistula healing and the secondary outcome measures assessed recurrence, continence status, and complications. RESULTS: A total of 166 patients with cryptoglandular complex perianal fistula (68.7% men, mean age 51.4 ± 13.2 years) were included. The majority of the fistulas (88.5%) were transsphincteric; 87.8% were relapsed fistulas, with a mean of 3.3 ± 3.1 previous procedures. The median time to recurrence-free healing was 26 ± 5 months (95% CI, 16–36). The 1-year follow-up was completed by 154 patients, 3-year follow-up by 140 patients, and 5-year follow-up by 132 patients. The estimated healing rate decreased over time, reaching 70.9% at 1 year, 42.8% at 3 years, and 24.3% at 5 years. Complications were absent in 92.7% of the cases. No changes in continence were observed in any patients. LIMITATIONS: Most patients presented with transsphincteric anal fistulas. CONCLUSIONS: Treatment of complex cryptoglandular anal fistula with platelet-rich plasma is safe and feasible in the long term. See Video Abstract. RESULTADOS A LARGO PLAZO DEL CIERRE PRIMARIO DE FÍSTULAS CON PLASMA RICO EN PLAQUETAS: UN ESTUDIO PROSPECTIVO: ANTECEDENTES: El tratamiento de las fístulas perianales complejas sigue siendo un reto y es necesario encontrar técnicas quirúrgicas que garanticen altas tasas de curación sin comprometer la continencia. El plasma rico en plaquetas se ha estudiado en diferentes disciplinas, y el tratamiento ha tenido éxito gracias a sus propiedades como regenerador de tejidos. OBJETIVO: Evaluar la tasa de curación a 5 años y las complicaciones en pacientes con fístulas perianales complejas tratadas con terapia con plasma. DISEÑO: Estudio prospectivo y observacional realizado entre el 2011 y el 2022. Los pacientes con fístula perianal compleja que cumplían los criterios de inclusión fueron tratados con plasma rico en factores de crecimiento. Se realizó un seguimiento y una evaluación durante 5 años después del tratamiento, con visitas a los 1, 3, 6, 12, 36 y 60 meses. ENTORNO: Este estudio se llevó a cabo en un único centro terciario de referencia. PACIENTES: Se evaluaron los datos de 166 pacientes. PRINCIPALES MEDIDAS DE RESULTADO: La medida de resultado principal fue la tasa de curación de la fístula y las medidas de resultado secundarias evaluaron la recurrencia, el estado de continencia y las complicaciones. RESULTADOS: Se incluyó un total de 166 pacientes con fístula perianal compleja criptoglandular (68,7 % hombres, edad media 51,4 ± 13,2 años). La mayoría de las fístulas (88,5 %) eran transesfinterianas; el 87,8 % eran fístulas recidivantes, con una media de 3,3 ± 3,1 procedimientos previos. El tiempo mediano hasta la curación sin recidivas fue de 26 ± 5 meses (IC del 95 %: [16-36]). El seguimiento de 1 año se completó en 154 pacientes, el de 3 años en 140 pacientes y el de 5 años en 132 pacientes. La tasa de curación estimada disminuyó con el tiempo, alcanzando el 70,9 % al año, el 42,8 % a los 3 años y el 24,3 % a los 5 años. No se observaron complicaciones en el 92,7 % de los casos. No se observaron cambios en la continencia en ningún paciente. LIMITACIONES: La mayoría de los pacientes presentaban fístulas anales transesfintericas. CONCLUSIONES: El tratamiento de la fístula anal criptoglandular compleja con plasma rico en plaquetas es seguro y viable a largo plazo. (Traducción—Yesenia Rojas-Khalil)
- 1 May 2025
- Published by Wiley in Colorectal Disease
- Vol. 27 (5) , e70107
Splenic flexure takedown: A step‐by‐step robotic versus laparoscopic comparison—A video vignette
- 1 May 2025
- Published by Wiley in Colorectal Disease
- Vol. 27 (5) , e70107
Splenic flexure takedown: A step‐by‐step robotic versus laparoscopic comparison—A video vignette
- 1 August 2024
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 67 (11) , 1450-1457
Comparative Study of Diluted Hydrogen Peroxide and Sulfur Hexafluoride in the Contrast-Enhanced Ultrasound Assessment of Anal Fistulas
BACKGROUND: Endoanal ultrasound for the diagnosis of anal fistulas requires the injection of hydrogen peroxide, but it is often uncomfortable for the patient and has the potential to cause complications. Novel ultrasound contrast is currently available. OBJECTIVE: To assess the efficacy and safety of sulfur hexafluoride as an ultrasound contrast agent for the diagnosis of a perianal fistula by comparing it with those of 50% diluted hydrogen peroxide. DESIGN: Double-blinded superiority study with 4 consecutive visits to perform an ultrasound without contrast, a hydrogen peroxide–enhanced ultrasound, a sulfur hexafluoride–enhanced ultrasound, and a rectal exploration in the operating room (the criterion standard). The 3 expert surgeon sonographers independently reviewed the ultrasound images. SETTING: This study was conducted at a single university hospital. PATIENTS: Data from 176 patients were evaluated. MAIN OUTCOME MEASURES: Demographic and exploratory data and the ultrasound findings related to the location of the internal fistula orifice, description of the primary and secondary tracts, and presence of cavities and sphincter defects were analyzed. Complications occurring before and after the contrast agent administration and pain score measured using a visual analog scale were considered. RESULTS: Eighty-eight patients were included (men: 71.5%; mean age: 48.3 years), with 62.5% having a complex type fistula and 83.7% having a transsphincteric type fistula. Sulfur hexafluoride–enhanced ultrasounds demonstrated a higher interobserver agreement in determining the secondary tracts (κ = 0.604) and anal fistula height (κ = 0.604) compared with other methods. Both hydrogen peroxide–enhanced ultrasound (90.91%) and sulfur hexafluoride–enhanced ultrasound (89.77%) detected the internal orifice more frequently than ultrasounds without contrast (62.5%; p < 0.001), with no differences between contrast agents (p = 0.810). Sulfur hexafluoride-enhanced ultrasound was less painful than peroxide–enhanced ultrasound (p < 0.001). LIMITATIONS: Most of the patients had transsphincteric anal fistulas. CONCLUSIONS: Sulfur hexafluoride proved comparable to hydrogen peroxide in evaluating fistulous tracts and identifying the internal orifice, and it significantly reduced pain and discomfort. Furthermore, it demonstrated a higher interobserver agreement in determining the secondary tracts and anal fistula height compared with other methods. See Video Abstract. ESTUDIO COMPARATIVO DE PERÓXIDO DE HIDRÓGENO DILUIDO Y HEXAFLUORURO DE AZUFRE EN LA EVALUACIÓN ECOGRÁFICA CON CONTRASTE DE FÍSTULAS ANALES: ANTECEDENTES: La ecografía endoanal para el diagnóstico de fístulas anales requiere la inyección de peróxido de hidrógeno, pero generalmente resulta incómoda para el paciente y presenta potenciales complicaciones. Actualmente se encuentran disponibles nuevos contrastes ecográficos. OBJETIVO: Evaluar la eficacia y seguridad del hexafluoruro de azufre como agente de contraste ecográfico para el diagnóstico de fístula perianal comparándolo con el peróxido de hidrógeno diluido al 50%. DISEÑO: Estudio de superioridad doble ciego con cuatro visitas consecutivas realizando una ecografía sin contraste, ecografía potenciada con peróxido de hidrógeno, ecografía potenciada con hexafluoruro de azufre y exploración rectal en el quirófano (el estándar de oro). Las imágenes ecográficas fueron revisadas de forma independiente por tres cirujanos ecografistas expertos. AJUSTE: Estudio llevado a cabo en un único hospital universitario. PACIENTES: Se evaluaron datos de 176 pacientes. PRINCIPALES MEDIDAS DE RESULTADO: Se analizaron los datos demográficos y exploratorios y los hallazgos ecográficos relacionados con la ubicación del orificio interno de la fístula, descripción de los trayectos primario y secundario y la presencia de cavidades y defectos del esfínter. Se consideraron las complicaciones ocurridas antes y después de la administración del agente de contraste y la presencia de dolor medido mediante un puntaje. RESULTADOS: Se incluyeron 88 pacientes (hombres: 71,5%; edad media: 48,3 años). El 62,5% fueron tipo complejo y el 83,7% tipo transesfintérico. Las ecografías mejoradas con hexafluoruro de azufre demostraron mayor concordancia interobservador en la determinación de los trayectos secundarios (κ = 0,604) y la altura de la fístula anal (κ = 0,604) en comparación con otros métodos. Tanto la ecografía con peróxido de hidrógeno (90,91%) como la ecografía con hexafluoruro de azufre (89,77%) detectaron con mayor frecuencia el orificio interno que la ecografía sin contraste (62,5%) (p < 0,001), sin diferencias entre agentes de contraste (p = 0,810). La ecografía potenciada con hexafluoruro de azufre fue menos dolorosa que la ecografía potenciada con peróxido (p < 0,001). LIMITACIONES: La mayoría de los pacientes presentaron fístulas anales transesfintéricas. CONCLUSIONES: El hexafluoruro de azufre demostró ser comparable al peróxido de hidrógeno en la evaluación de los trayectos fistulosos y la identificación del orificio interno y con reducción significativa del dolor y malestar. Además, demostró mayor concordancia interobservador en la determinación de los trayectos secundarios y la altura de la fístula anal en comparación con otros métodos. (Traducción—Dr. Fidel Ruiz Healy)
- 1 August 2024
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 67 (11) , 1450-1457
Comparative Study of Diluted Hydrogen Peroxide and Sulfur Hexafluoride in the Contrast-Enhanced Ultrasound Assessment of Anal Fistulas
BACKGROUND: Endoanal ultrasound for the diagnosis of anal fistulas requires the injection of hydrogen peroxide, but it is often uncomfortable for the patient and has the potential to cause complications. Novel ultrasound contrast is currently available. OBJECTIVE: To assess the efficacy and safety of sulfur hexafluoride as an ultrasound contrast agent for the diagnosis of a perianal fistula by comparing it with those of 50% diluted hydrogen peroxide. DESIGN: Double-blinded superiority study with 4 consecutive visits to perform an ultrasound without contrast, a hydrogen peroxide–enhanced ultrasound, a sulfur hexafluoride–enhanced ultrasound, and a rectal exploration in the operating room (the criterion standard). The 3 expert surgeon sonographers independently reviewed the ultrasound images. SETTING: This study was conducted at a single university hospital. PATIENTS: Data from 176 patients were evaluated. MAIN OUTCOME MEASURES: Demographic and exploratory data and the ultrasound findings related to the location of the internal fistula orifice, description of the primary and secondary tracts, and presence of cavities and sphincter defects were analyzed. Complications occurring before and after the contrast agent administration and pain score measured using a visual analog scale were considered. RESULTS: Eighty-eight patients were included (men: 71.5%; mean age: 48.3 years), with 62.5% having a complex type fistula and 83.7% having a transsphincteric type fistula. Sulfur hexafluoride–enhanced ultrasounds demonstrated a higher interobserver agreement in determining the secondary tracts (κ = 0.604) and anal fistula height (κ = 0.604) compared with other methods. Both hydrogen peroxide–enhanced ultrasound (90.91%) and sulfur hexafluoride–enhanced ultrasound (89.77%) detected the internal orifice more frequently than ultrasounds without contrast (62.5%; p < 0.001), with no differences between contrast agents (p = 0.810). Sulfur hexafluoride-enhanced ultrasound was less painful than peroxide–enhanced ultrasound (p < 0.001). LIMITATIONS: Most of the patients had transsphincteric anal fistulas. CONCLUSIONS: Sulfur hexafluoride proved comparable to hydrogen peroxide in evaluating fistulous tracts and identifying the internal orifice, and it significantly reduced pain and discomfort. Furthermore, it demonstrated a higher interobserver agreement in determining the secondary tracts and anal fistula height compared with other methods. See Video Abstract. ESTUDIO COMPARATIVO DE PERÓXIDO DE HIDRÓGENO DILUIDO Y HEXAFLUORURO DE AZUFRE EN LA EVALUACIÓN ECOGRÁFICA CON CONTRASTE DE FÍSTULAS ANALES: ANTECEDENTES: La ecografía endoanal para el diagnóstico de fístulas anales requiere la inyección de peróxido de hidrógeno, pero generalmente resulta incómoda para el paciente y presenta potenciales complicaciones. Actualmente se encuentran disponibles nuevos contrastes ecográficos. OBJETIVO: Evaluar la eficacia y seguridad del hexafluoruro de azufre como agente de contraste ecográfico para el diagnóstico de fístula perianal comparándolo con el peróxido de hidrógeno diluido al 50%. DISEÑO: Estudio de superioridad doble ciego con cuatro visitas consecutivas realizando una ecografía sin contraste, ecografía potenciada con peróxido de hidrógeno, ecografía potenciada con hexafluoruro de azufre y exploración rectal en el quirófano (el estándar de oro). Las imágenes ecográficas fueron revisadas de forma independiente por tres cirujanos ecografistas expertos. AJUSTE: Estudio llevado a cabo en un único hospital universitario. PACIENTES: Se evaluaron datos de 176 pacientes. PRINCIPALES MEDIDAS DE RESULTADO: Se analizaron los datos demográficos y exploratorios y los hallazgos ecográficos relacionados con la ubicación del orificio interno de la fístula, descripción de los trayectos primario y secundario y la presencia de cavidades y defectos del esfínter. Se consideraron las complicaciones ocurridas antes y después de la administración del agente de contraste y la presencia de dolor medido mediante un puntaje. RESULTADOS: Se incluyeron 88 pacientes (hombres: 71,5%; edad media: 48,3 años). El 62,5% fueron tipo complejo y el 83,7% tipo transesfintérico. Las ecografías mejoradas con hexafluoruro de azufre demostraron mayor concordancia interobservador en la determinación de los trayectos secundarios (κ = 0,604) y la altura de la fístula anal (κ = 0,604) en comparación con otros métodos. Tanto la ecografía con peróxido de hidrógeno (90,91%) como la ecografía con hexafluoruro de azufre (89,77%) detectaron con mayor frecuencia el orificio interno que la ecografía sin contraste (62,5%) (p < 0,001), sin diferencias entre agentes de contraste (p = 0,810). La ecografía potenciada con hexafluoruro de azufre fue menos dolorosa que la ecografía potenciada con peróxido (p < 0,001). LIMITACIONES: La mayoría de los pacientes presentaron fístulas anales transesfintéricas. CONCLUSIONES: El hexafluoruro de azufre demostró ser comparable al peróxido de hidrógeno en la evaluación de los trayectos fistulosos y la identificación del orificio interno y con reducción significativa del dolor y malestar. Además, demostró mayor concordancia interobservador en la determinación de los trayectos secundarios y la altura de la fístula anal en comparación con otros métodos. (Traducción—Dr. Fidel Ruiz Healy)
- Open Access
- 29 September 2023
- Published by Romanian Society of Gastroenterology and Hepatology in Journal of Gastrointestinal and Liver Diseases
- Vol. 32 (3) , 384-392
Efficacy of Sacral Nerve Stimulation in Non-constipated Irritable Bowel Syndrome Patients: A Systematic Review
Background and Aims: Irritable bowel syndrome (IBS) is a prevalent disorder with a complex and heterogeneous physiopathology, including a dysregulation of gut-brain axis. Treatment for IBS is targeted to the predominant symptom and requires a multidisciplinary approach. This review aims to evaluate the efficacy and safety of sacral nerve stimulation in non-constipated IBS patients Methods: A literature search was carried out on MEDLINE, The Cochrane Central Register of Controlled Trials (CENTRAL) and Web of Science databases for all relevant articles. Quality of included papers was assessed using standardized guidelines Results: Of 129 initial citations, 7 articles met our predefined inclusion criteria, including five randomized trials, a pilot study and a descriptive follow-up study. Five of 7 studies reported a positive effect of sacral nerve stimulation on symptoms and quality of life improvement in non-constipated IBS patients. No study reported serious adverse events. Conclusions: Despite initial promising results of sacral nerve stimulation in non-constipated IBS patients, studies with larger sample sizes and longer follow-up are required.
- 29 September 2023
- Published by Romanian Society of Gastroenterology and Hepatology in Journal of Gastrointestinal and Liver Diseases
- Vol. 32 (3) , 384-392
Open AccessEfficacy of Sacral Nerve Stimulation in Non-constipated Irritable Bowel Syndrome Patients: A Systematic Review
Background and Aims: Irritable bowel syndrome (IBS) is a prevalent disorder with a complex and heterogeneous physiopathology, including a dysregulation of gut-brain axis. Treatment for IBS is targeted to the predominant symptom and requires a multidisciplinary approach. This review aims to evaluate the efficacy and safety of sacral nerve stimulation in non-constipated IBS patients Methods: A literature search was carried out on MEDLINE, The Cochrane Central Register of Controlled Trials (CENTRAL) and Web of Science databases for all relevant articles. Quality of included papers was assessed using standardized guidelines Results: Of 129 initial citations, 7 articles met our predefined inclusion criteria, including five randomized trials, a pilot study and a descriptive follow-up study. Five of 7 studies reported a positive effect of sacral nerve stimulation on symptoms and quality of life improvement in non-constipated IBS patients. No study reported serious adverse events. Conclusions: Despite initial promising results of sacral nerve stimulation in non-constipated IBS patients, studies with larger sample sizes and longer follow-up are required.
- Open Access
- 21 July 2023
- Published by MDPI AG in Applied Sciences
- Vol. 13 (14) , 8420
Technology-Enhanced Learning in Health Sciences: Improving the Motivation and Performance of Medical Students with Immersive Reality
Numerous studies suggest that immersive reality (IR) is an educational technology with great potential in the field of health sciences. Its integration allows for an increase in the motivation and academic performance of students. In this sense, this research aims to study the self-perception of motivation and performance levels obtained by students who are completing their degree in medicine at the University of Seville after experiencing a session with IR. To achieve this, 136 student participants answered two questionnaires, the IMMS and the academic performance test. The results show high levels of motivation during the IR session, where the interaction with “hot spots” predominates. In the same way, the measured performance results are quite great. For this reason, it is concluded that the potential of using IR as an educational technology is evident, and new lines of related research are opened.
- 21 July 2023
- Published by MDPI AG in Applied Sciences
- Vol. 13 (14) , 8420
Open AccessTechnology-Enhanced Learning in Health Sciences: Improving the Motivation and Performance of Medical Students with Immersive Reality
Numerous studies suggest that immersive reality (IR) is an educational technology with great potential in the field of health sciences. Its integration allows for an increase in the motivation and academic performance of students. In this sense, this research aims to study the self-perception of motivation and performance levels obtained by students who are completing their degree in medicine at the University of Seville after experiencing a session with IR. To achieve this, 136 student participants answered two questionnaires, the IMMS and the academic performance test. The results show high levels of motivation during the IR session, where the interaction with “hot spots” predominates. In the same way, the measured performance results are quite great. For this reason, it is concluded that the potential of using IR as an educational technology is evident, and new lines of related research are opened.
- 23 June 2023
- Published by Wiley in Colorectal Disease
- Vol. 25 (8) , 1731-1732
Treatment of rectourethral fistula by a robotic approach: a video vignette
- 23 June 2023
- Published by Wiley in Colorectal Disease
- Vol. 25 (8) , 1731-1732
Treatment of rectourethral fistula by a robotic approach: a video vignette